arrow
M

Michael F. Berger

Memorial Sloan Kettering Cancer Center
H指数:131
被引数:9.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial

不可切除的III期非小细胞肺癌中,Canakinumab联合化放疗和Durvalumab巩固治疗:CHORUS I/II期试验

2026-09-070
OAAI
Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer

整合临床基因组学分析揭示了晚期结直肠癌的演进和转移趋向

2026-09-010
PRE
Expanding the phenotype of hereditary renal cell carcinoma syndromes: implications for surveillance and management

扩展遗传性肾细胞癌综合征的表型:对监测和管理的意义

2026-08-240
OAAI
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial

Pembrolizumab和olaparib治疗同源重组缺陷型转移性胰腺癌: 2期POLAR试验

2026-03-250
OAAI
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

乳腺癌的同源重组缺陷和半合子驱动抵抗

Nature
IF48.5
2026-03-040
OAAI
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

尿路上皮癌对HER2靶向抗体药物偶联物的敏感性决定因素

2025-12-200
OAAI
Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancer

器官保留的局部晚期直肠癌患者的超敏ctDNA监测

2025-12-110
OA
Clinical Significance of MTAP Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung Cancer

MTAP缺失的临床意义及其与非小细胞肺癌中包括EGFR在内的并发致癌驱动基因改变的重叠情况

2025-11-170
PRE
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA

使用细胞游离DNA追踪卵巢癌治疗过程中的克隆进化

Nature
IF48.5
2025-10-010
OA
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors

胶质瘤和神经胶质神经元肿瘤患者胚系变异的前瞻性表征

2025-09-120
OAAI
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy

种系遗传变异影响克隆造血景观和发展为恶性肿瘤

2025-07-150
OAAI
REAL-WORLD EXPERIENCE WITH CIRCULATING TUMOR DNA IN CEREBROSPINAL FLUID IN PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMORS
2024-11-110
PRE
PROSPECTIVE GERMLINE SEQUENCING OF PATIENTS WITH GLIOMAS, GLIONEURONAL OR NEURONAL TUMORS
2024-11-110
PRE
UTILITY OF CIRCULATING TUMOR DNA (CTDNA) FROM CEREBROSPINAL FLUID (CSF) FOR PROGNOSIS OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
2024-11-110
PRE
Automated real-world data integration improves cancer outcome prediction

自动化的真实世界数据集成可改善癌症结果预测

Nature
IF48.5
2024-11-060
OAAI
Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia

多组学分析确定非裔美国急性髓系白血病患者的生存预测因子

2024-10-041
OAAI